AstraZeneca Financial Overview
AstraZeneca's market cap is currently $287.39B. The company's EPS TTM is $2.38; its P/E ratio is 30.18; and it has a dividend yield of 1.72%. AstraZeneca is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $2.12. See an overview of income statement, balance sheet, and cash flow financials.
